Charlie McDermott
North America, California, United States
Description
Charlie McDermott, Chairman, President & Chief Executive Officer at Primmune Therapeutics.
Investor Profile
Charlie McDermott has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Charlie McDermott frequently co-invest with?
What are some of recent deals done by Charlie McDermott?
Find More Investors Like Charlie McDermott
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
